PP_1170x120_10-25-21

Dr. Steven Hitchcock

Evotec and Takeda ink research deal

Evotec and Takeda ink research deal

HAMBURG, Germany — Evotec SE announced that Evotec GT, with operations in Austria, has established a long-term research alliance with Takeda to support Takeda’s growing number of research stage gene therapy discovery programs. Evotec GT is an integral part of Evotec’s integrated fully modality-agnostic drug discovery platform that combines all activities involved with the discovery,